Terns Pharmaceuticals, Inc. short interest in 2023
In 2023, Terns Pharmaceuticals, Inc.'s disclosed short interest ran from 2.76% of shares outstanding on 13 Jan 2023 to 7.63% on 29 Dec 2023, a change of +4.87 percentage points. The year's high was 9.42% on 13 Oct 2023 and its low 2.76% on 13 Jan 2023, averaging 6.44% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.38 days on 30 Nov 2023. Full history: Terns Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 2.76% (13 Jan 2023)
- End of year
- 7.63% (29 Dec 2023)
- Change
- +4.87 pp
- High
- 9.42% (13 Oct 2023)
- Low
- 2.76% (13 Jan 2023)
- Average
- 6.44%
- Highest days to cover
- 18.38 (30 Nov 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 2.76% | 5.39 | |
| 31 Jan 2023 | 3.05% | 8.94 | |
| 15 Feb 2023 | 4.68% | 4.67 | |
| 28 Feb 2023 | 4.50% | 3.34 | |
| 15 Mar 2023 | 3.44% | 9.04 | |
| 31 Mar 2023 | 4.43% | 4.24 | 10-K filed, results (8-K) |
| 14 Apr 2023 | 4.68% | 9.78 | |
| 28 Apr 2023 | 5.06% | 7.53 | |
| 15 May 2023 | 5.24% | 7.86 | 10-Q filed, results (8-K) |
| 31 May 2023 | 5.51% | 4.66 | |
| 15 Jun 2023 | 6.06% | 6.06 | |
| 30 Jun 2023 | 7.64% | 1.95 | |
| 14 Jul 2023 | 7.77% | 6.98 | |
| 31 Jul 2023 | 7.74% | 7.03 | |
| 15 Aug 2023 | 7.78% | 5.56 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 7.83% | 10.43 | |
| 15 Sep 2023 | 8.69% | 13.23 | |
| 29 Sep 2023 | 8.96% | 8.16 | |
| 13 Oct 2023 | 9.42% | 12.41 | |
| 31 Oct 2023 | 8.57% | 10.71 | |
| 15 Nov 2023 | 8.25% | 11.84 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 7.79% | 18.38 | |
| 15 Dec 2023 | 7.15% | 5.19 | |
| 29 Dec 2023 | 7.63% | 12.51 |
See also: Terns Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.